AMLX Nov 2024 4.000 call
| Previous close | 0.4000 |
| Open | 0.4000 |
| Bid | 0.1000 |
| Ask | 0.3500 |
| Strike | 4.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.4000 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 86 |
GuruFocus.comDirector Karen Firestone Acquires 50,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
Following this transaction, the insider now owns a total of 55,000 shares of Amylyx Pharmaceuticals Inc. Amylyx Pharmaceuticals Inc is engaged in the development of innovative treatments aimed at stopping the progression of neurodegenerative diseases, including ALS and Alzheimer's disease. Over the past year, Karen Firestone has bought a total of 54,000 shares and has not sold any shares.
GuruFocus.comDirector MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
Following this transaction, the insider now owns a total of 858,571 shares of Amylyx Pharmaceuticals Inc. Amylyx Pharmaceuticals Inc is engaged in the development of innovative treatments aimed at stopping the progression of neurodegenerative diseases, including ALS and Alzheimer's disease. Over the past year, MILNE GEORGE M JR has purchased a total of 100,000 shares and has not sold any shares.
Business WireAmylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass., August 28, 2024--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") today announced that management will participate in the following upcoming investor conferences, which are being conducted in-person in New York City:
